Invivyd (NASDAQ:IVVD) Earns “Buy” Rating from HC Wainwright

Invivyd (NASDAQ:IVVD)‘s stock had its “buy” rating reiterated by investment analysts at HC Wainwright in a research report issued on Tuesday, Benzinga reports. They currently have a $15.00 price objective on the stock.

Invivyd Stock Down 24.6 %

Shares of IVVD stock traded down $0.32 on Tuesday, reaching $0.97. The company had a trading volume of 1,685,564 shares, compared to its average volume of 688,179. The business’s 50-day moving average is $1.15 and its 200 day moving average is $2.32. Invivyd has a one year low of $0.84 and a one year high of $5.20. The stock has a market capitalization of $116.03 million, a PE ratio of -0.55 and a beta of 0.66.

Insiders Place Their Bets

In other news, Director Terrance Mcguire sold 112,381 shares of Invivyd stock in a transaction on Wednesday, May 29th. The shares were sold at an average price of $1.66, for a total value of $186,552.46. Following the completion of the sale, the director now owns 4,688,079 shares in the company, valued at approximately $7,782,211.14. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this hyperlink. Company insiders own 17.90% of the company’s stock.

Hedge Funds Weigh In On Invivyd

A number of hedge funds have recently bought and sold shares of IVVD. Vanguard Group Inc. raised its stake in shares of Invivyd by 3.9% during the 1st quarter. Vanguard Group Inc. now owns 2,611,202 shares of the company’s stock worth $11,594,000 after purchasing an additional 97,496 shares during the period. Marshall Wace LLP raised its stake in shares of Invivyd by 4.2% during the 2nd quarter. Marshall Wace LLP now owns 786,899 shares of the company’s stock worth $866,000 after purchasing an additional 31,992 shares during the period. Acadian Asset Management LLC raised its stake in shares of Invivyd by 232.0% during the 2nd quarter. Acadian Asset Management LLC now owns 678,706 shares of the company’s stock worth $745,000 after purchasing an additional 474,301 shares during the period. Duquesne Family Office LLC bought a new stake in shares of Invivyd during the 2nd quarter worth $629,000. Finally, Jacobs Levy Equity Management Inc. raised its stake in shares of Invivyd by 21.7% during the 1st quarter. Jacobs Levy Equity Management Inc. now owns 435,338 shares of the company’s stock worth $1,933,000 after purchasing an additional 77,603 shares during the period. 70.36% of the stock is owned by hedge funds and other institutional investors.

About Invivyd

Invivyd, Inc, a commercial-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of antibody-based solutions for infectious diseases in the United States. The company developed INVYMAB, a platform that combines viral surveillance and predictive modeling with advanced antibody engineering.